AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 59 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $428,000 | -37.7% | 85,000 | 0.0% | 0.00% | -42.9% |
Q2 2020 | $687,000 | +329.4% | 85,000 | +37.1% | 0.01% | +250.0% |
Q4 2018 | $160,000 | -41.2% | 62,000 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $272,000 | -28.4% | 62,000 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $380,000 | -15.9% | 62,000 | 0.0% | 0.01% | -25.0% |
Q1 2018 | $452,000 | -11.0% | 62,000 | 0.0% | 0.01% | -11.1% |
Q4 2017 | $508,000 | -56.4% | 62,000 | -44.1% | 0.01% | -55.0% |
Q3 2017 | $1,166,000 | -4.7% | 111,000 | 0.0% | 0.02% | -13.0% |
Q2 2017 | $1,224,000 | +13.9% | 111,000 | 0.0% | 0.02% | +9.5% |
Q1 2017 | $1,075,000 | – | 111,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |